Novavax, Inc.
CH ˙ SWX ˙ US6700024010
SecurityCH:NVAX / Novavax, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Vanguard Group Inc ownership in NVAX / Novavax, Inc.

2026-03-27 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Novavax, Inc. (CH:NVAX). This represents 0.0 percent ownership of the company. In their previous filing dated 2024-11-12 , Vanguard Group Inc had reported owning 15,430,034 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-03-27 2026-03-27 13G/A 15,430,034 0 -100.00 0.00 -100.00
2024-11-12 2024-11-12 13G/A 15,430,034 15,430,034 0.00 9.63 0.00
2024-11-04 2024-11-04 13G/A 14,560,054 15,430,034 5.98 9.63 -21.45
2024-02-13 2024-02-13 13G/A 8,844,653 14,560,054 64.62 12.26 17.77
2023-02-09 2023-02-09 13G/A 7,992,228 8,844,653 10.67 10.41 2.26
2022-12-12 2022-12-12 13G/A 6,897,007 7,992,228 15.88 10.18 11.62
2022-02-10 2022-02-10 13G/A 5,598,760 6,897,007 23.19 9.12 3.75
2021-02-10 2021-02-10 13G 1,481,859 5,598,760 277.82 8.79 90.67
2020-02-12 2020-02-12 13G/A 21,168,796 1,481,859 -93.00 4.61 -16.49
2019-02-11 2019-02-11 13G 14,386,865 21,168,796 47.14 5.52 24.04
2018-02-09 2018-02-09 13G/A 20,742,737 14,386,865 -30.64 4.45 -41.75
2017-02-10 2017-02-10 13G/A 18,017,812 20,742,737 15.12 7.64 14.54
2016-02-11 2016-02-11 13G 18,017,812 6.67

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F NOVAVAX COM NEW 670002401 15,470,365 275,802 1.82 103,961 -21.08 0.0015
2025-11-07 2025-09-30 13F NOVAVAX COM NEW 670002401 15,194,563 -238,649 -1.55 131,737 35.49 0.0020
2025-08-11 2025-06-30 13F NOVAVAX COM NEW 670002401 15,433,212 -241,166 -1.54 97,229 -3.23 0.0016
2025-05-09 2025-03-31 13F NOVAVAX COM NEW 670002401 15,674,378 -51,872 -0.33 100,473 -20.54 0.0018
2025-02-11 2024-12-31 13F NOVAVAX COM NEW 670002401 15,726,250 296,181 1.92 126,439 -35.12 0.0022
2024-11-13 2024-09-30 13F NOVAVAX COM NEW 670002401 15,430,069 1,354,696 9.62 194,882 9.36 0.0035
2024-08-13 2024-06-30 13F NOVAVAX COM NEW 670002401 14,075,373 582,099 4.31 178,194 176.28 0.0034
2024-05-10 2024-03-31 13F NOVAVAX COM NEW 670002401 13,493,274 -1,066,787 -7.33 64,498 -7.71 0.0013
2024-03-11 2023-12-31 13F/A-1 NOVAVAX COM NEW 670002401 14,560,061 3,008,585 26.05 69,888 -16.43 0.0015
2024-02-14 2023-12-31 13F NOVAVAX COM NEW 670002401 14,560,061 3,008,585 69,888 0.0015
2023-12-18 2023-09-30 13F/A-1 NOVAVAX COM NEW 670002401 11,551,476 978,873 9.26 83,633 6.46 0.0021
2023-11-14 2023-09-30 13F NOVAVAX COM NEW 670002401 11,551,476 978,873 83,633 0.0021
2023-08-14 2023-06-30 13F NOVAVAX COM NEW 670002401 10,572,603 378,645 3.71 78,554 11.20 0.0019
2023-07-14 2023-03-31 13F/A-1 NOVAVAX COM NEW 670002401 10,193,958 1,349,305 15.26 70,644 -22.30 0.0018
2023-05-15 2023-03-31 13F NOVAVAX COM NEW 670002401 10,193,958 1,349,305 70,644 0.0018
2023-02-10 2022-12-31 13F NOVAVAX COM NEW 670002401 8,844,653 1,348,729 17.99 90,923 -33.35 0.0025
2022-11-14 2022-09-30 13F NOVAVAX COM NEW 670002401 7,495,924 144,999 1.97 136,426 -63.91 0.0040
2022-08-12 2022-06-30 13F NOVAVAX COM NEW 670002401 7,350,925 383,982 5.51 378,058 -26.32 0.0106
2022-05-13 2022-03-31 13F NOVAVAX COM NEW 670002401 6,966,943 69,936 1.01 513,116 -48.00 0.0121
2022-02-14 2021-12-31 13F NOVAVAX COM NEW 670002401 6,897,007 100,009 1.47 986,754 -29.97 0.0224
2021-11-12 2021-09-30 13F NOVAVAX COM NEW 670002401 6,796,998 126,338 1.89 1,409,086 -0.51 0.0350
2021-08-13 2021-06-30 13F NOVAVAX COM NEW 670002401 6,670,660 777,356 13.19 1,416,249 32.54 0.0352
2021-05-14 2021-03-31 13F NOVAVAX COM NEW 670002401 5,893,304 294,544 5.26 1,068,514 71.15 0.0289
2021-02-12 2020-12-31 13F NOVAVAX COM NEW 670002401 5,598,760 167,200 3.08 624,317 6.08 0.0181
2020-11-16 2020-09-30 13F NOVAVAX COM NEW 670002401 5,431,560 793,923 17.12 588,509 52.25 0.0195
2020-08-14 2020-06-30 13F NOVAVAX COM NEW 670002401 4,637,637 2,579,671 125.35 386,547 1,283.14 0.0137
2020-05-15 2020-03-31 13F NOVAVAX COM NEW 670002401 2,057,966 576,107 38.88 27,947 373.92 0.0012
2020-02-14 2019-12-31 13F NOVAVAX COM NEW 670002401 1,481,859 -64,975 -4.20 5,897 -24.06 0.0002
2019-11-14 2019-09-30 13F NOVAVAX COM NEW 670002401 1,546,834 146,168 10.44 7,765 -5.40 0.0003
2019-08-14 2019-06-30 13F NOVAVAX COM NEW 670002401 1,400,666 -24,800,602 -94.65 8,208 -43.14 0.0003
2019-05-15 2019-03-31 13F NOVAVAX COM 670002104 26,201,268 5,032,472 23.77 14,435 -62.94 0.0006
2019-02-14 2018-12-31 13F NOVAVAX COM 670002104 21,168,796 -1,162,659 -5.21 38,950 -7.22 0.0018
2018-12-13 2018-09-30 13F/A-2 NOVAVAX COM 670002104 22,331,455 1,291,644 6.14 41,982 48.91 0.0016
2018-11-23 2018-09-30 13F/A-1 NOVAVAX COM 670002104 22,331,455 0 41,982 0.0016
2018-11-14 2018-09-30 13F NOVAVAX COM 670002104 22,331,455 1,291,644 41,982
2018-08-14 2018-06-30 13F NOVAVAX COM 670002104 21,039,811 4,968,229 30.91 28,193 -16.47 0.0012
2018-05-15 2018-03-31 13F NOVAVAX COM 670002104 16,071,582 1,684,717 11.71 33,750 89.19 0.0015
2018-02-14 2017-12-31 13F NOVAVAX COM 670002104 14,386,865 1,557,143 12.14 17,839 21.97 0.0008
2017-11-14 2017-09-30 13F NOVAVAX COM 670002104 12,829,722 -4,566,383 -26.25 14,626 -26.89 0.0007
2017-08-24 2017-06-30 13F/A-1 NOVAVAX COM 670002104 17,396,105 -4,285,213 -19.76 20,006 -27.91 0.0010
2017-08-11 2017-06-30 13F NOVAVAX COM 670002104 17,396,105 -4,285,213 20,006
2017-05-12 2017-03-31 13F NOVAVAX COM 670002104 21,681,318 938,581 4.52 27,752 6.18 0.0014
2017-02-14 2016-12-31 13F NOVAVAX COM 670002104 20,742,737 526,925 2.61 26,136 -37.84 0.0015
2016-11-14 2016-09-30 13F NOVAVAX COM 670002104 20,215,812 280,798 1.41 42,048 -70.99 0.0025
2016-08-10 2016-06-30 13F NOVAVAX COM 670002104 19,935,014 1,385,637 7.47 144,928 51.42 0.0090
2016-05-13 2016-03-31 13F NOVAVAX COM 670002104 18,549,377 531,565 2.95 95,715 -36.68 0.0062
2016-02-08 2015-12-31 13F NOVAVAX COM 670002104 18,017,812 385,719 2.19 151,169 21.27 0.0102
2015-11-12 2015-09-30 13F/A-1 NOVAVAX COM 670002104 17,632,093 1,365,260 8.39 124,659 -31.21 0.0053
2015-11-12 2015-09-30 13F/A-1 NOVAVAX COM 670002104 17,632,093 1,365,260 124,659 0.0053
2015-08-13 2015-06-30 13F NOVAVAX COM 670002104 16,266,833 3,873,990 31.26 181,212 76.81 0.0122
2015-05-15 2015-03-31 13F/A-1 NOVAVAX COM 670002104 12,392,843 5,037,248 68.48 102,489 134.96 0.0070
2015-05-14 2015-03-31 13F NOVAVAX COM 670002104 12,392,843 102,489
2015-02-12 2014-12-31 13F NOVAVAX COM 670002104 7,355,595 273,568 3.86 43,619 47.70 0.0031
2014-11-12 2014-09-30 13F NOVAVAX COM 670002104 7,082,027 250,643 3.67 29,532 -6.43 0.0023
2014-08-11 2014-06-30 13F NOVAVAX COM 670002104 6,831,384 889,328 14.97 31,561 17.25 0.0025
2014-05-13 2014-03-31 13F NOVAVAX COM 670002104 5,942,056 458,222 8.36 26,918 -4.13 0.0023
2014-02-12 2013-12-31 13F NOVAVAX COM 670002104 5,483,834 1,202,524 28.09 28,077 107.53 0.0025
2013-11-07 2013-09-30 13F NOVAVAX COM 670002104 4,281,310 618,835 16.90 13,529 80.19 0.0013
2013-08-13 2013-06-30 13F NOVAVAX COM 670002104 3,662,475 3,662,475 7,508 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.